Details for 2020214749

Up to date per 05.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON KREBS MIT IMMUNE CHECKPOINT-HEMMER; ANTIKÖRPER, BINDET AN PROGRAMMIERTER ZELLTOD-1-REZEPTOR (PD-1) ODER PROGRAMMIERTE TOD LIGAND 1 (PD-L1)

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020214749

EP Publication Number

3858859

E-Number

1851491

Language

PCT Number

Publication Date

04.08.2021 A

29.10.2025 B1

Registration Date

29.10.2025

AT Publication Date

15.11.2025

Application Date

14.07.2016

Registration Number

Priorities

14.07.2015

201562192396 P

IPC

C07K 16/28 20060101AFI20210611BHEP

Maximum Duration of Protection

14.07.2036

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

No representatives present

Inventor

MANEKAS, Demetrios14 Yosemite Road Howell, New Jersey 07731US

GROSSO, JosephRt. 206&Province Line Road Princeton, New Jersey 08543US

ANDERSON, JeffreyRt. 206&Province Line Road Princeton, New Jersey 08543US

Information about Fees